Figure 1.
Management of breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) (modified from Clemens et al.: Clin Plast Surg 2015; 42: 605–13 [28])
ALK, Anaplastic lymphoma kinase; BfARM, Federal Institute for Drugs and Medical Devices; DGPRÄC, German Society of Plastic, Reconstructive, and Aesthetic Surgeons; FDA, Food and Drug Administration; PET-CT, positron-emission tomography/computed tomography
